Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02685930 · ClinicalTrials.gov registry record
Pneumonia in the Intensive Care Unit (ICU) Setting
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 364
- Enrollment target
NCT02685930: Completed study, sponsored by Washington University School of Medicine.
NCT02685930 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 364 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02685930 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 364 participants
- Enrollment target
Study Summary
The purpose of this observational study is to collect prospective data on the occurrence of bacterial and viral pneumonia in the ICU setting. Current classification systems for pneumonia promote over treatment with antibiotics as they do not specifically recognize the presence of culture-negative and viral pneumonia. The investigators will collect data to determine if a novel pneumonia classification system can be developed that more accurately links the etiology of pneumonia (antibiotic-susceptible bacterial pneumonia, antibiotic-resistant bacterial pneumonia, culture-negative pneumonia, viral pneumonia) to clinical outcomes. Additionally, the investigators will collect data on the practice of antimicrobial stewardship in the ICU setting to determine if further improvements in antibiotic practices can be accomplished in the future.
Interventions
- BEHAVIORAL Antibiotic de-escalation by ICU stewardship team with decreased exposure to broad spectrum antibiotics and shorter duration of therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 364 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-02-01 |
What the finished NCT02685930 record still lists
NCT02685930 is an observational study that tracks outcomes without assigning an intervention. The registered 364 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Antibiotic de-escalation by ICU stewardship team with decreased exposure to broad spectrum antibiotics and shorter duration of therapy is the first listed.
NCT02685930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02685930 about?
NCT02685930 is a clinical study titled "Pneumonia in the Intensive Care Unit (ICU) Setting". The purpose of this observational study is to collect prospective data on the occurrence of bacterial and viral pneumonia in the ICU setting. Current classification systems for pneumonia promote over treatment with antibiotics as they do not specifically recognize the presence of culture-negative an...
What is the current status of trial NCT02685930?
This trial is currently completed. The enrollment target is 364 participants. The study started on 2016-01. Estimated completion is 2017-02-01.
What interventions are being tested in trial NCT02685930?
The interventions under investigation include: Antibiotic de-escalation by ICU stewardship team with decreased exposure to broad spectrum antibiotics and shorter duration of therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02685930?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510597 · 364 participants · Phase 3
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- NCT05098132 · 364 participants · Phase 1
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- NCT05330221 · 364 participants · NA
Project 2: ACHIEVE- HF
- NCT05673148 · 364 participants · Phase 3
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia